Teriparatide products — Medical Mutual
Chronic hypoparathyroidism, previous Natpara users
Initial criteria
- Patient has tried Natpara
- AND Natpara is not available
- AND age ≥18 years
- AND prescribed by or in consultation with an endocrinologist
- AND patient is responding to therapy (reduction in oral calcium/vitamin D dose or stable serum calcium level)
Reauthorization criteria
- Patient continues to respond to therapy and cumulative therapy ≤2 years
Approval duration
1 year (initial); 1 year (reauth); max 2 years total